• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声引导衰减参数(UGAP)用于定量肝脂肪变性,以受控衰减参数(CAP)作为参考方法。

Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method.

机构信息

University of Medicine and Pharmacy "Victor Babes" Timisoara.

出版信息

Med Ultrason. 2021 Feb 18;23(1):7-14. doi: 10.11152/mu-2688. Epub 2020 Oct 8.

DOI:10.11152/mu-2688
PMID:33220028
Abstract

AIM

Nonalcoholic Fatty Liver Disease (NAFLD) is increasing in frequency in daily practice and evaluation of liver steatosis, fibrosis and inflammation severity are essential for prognosis assessment. The aim was to evaluate the usefulnessof a new liver steatosis quantification system - Ultrasound-Guided Attenuation Parameter (UGAP) from General Electric Healthcare, using Controlled Attenuation Parameter (CAP) as the reference method.

MATERIAL AND METHOD

179 consecutive subjects, in whom liver steatosis was assessed in the same session using UGAP, implemented on LOGIQ E10 system (GE Healthcare), and CAP (FibroScan, EchoSens). To discriminate between steatosis stages by CAP, we used the cut-offs recommended by the manufacturer: S1 (mild) - 230 dB/m, S2 (moderate) - 275 dB/m, S3 (severe) - 300 dB/m.

RESULTS

We classified our cohort by means of CAP into the following groups: S0 (no steatosis): 48/176 (27.2%), S1 (mild): 56/176 (31.6%), S2 (moderate): 14/176 (7.3%) and S3 (severe): 59/176 (33.9%). The mean UGAP values increased with the steatosis grade and for each group were the following: S0: 198.3±25.7 dB/m, S1: 216.86±26.3 dB/m, S2: 237.79±26.3 dB/m, and S3: 270.8±31.62 dB/m respectively (p<0.001). A very good positive correlation was found between UGAP and CAP values (r=0.73, p<0.0001). The best cut-off values for predicting different grades of liver steatosis using CAP as the reference were: S1 - 192.5 dB/m (AUC 0.83); S2 - 231 dB/m (AUC 0.90) and S3 - 248 dB/m (AUC 0.91).

CONCLUSION

UGAP seems to be a good method for liver steatosis quantification and correlates strongly with CAP values.

摘要

目的

非酒精性脂肪性肝病(NAFLD)在日常实践中发病率不断增加,因此评估肝脏脂肪变性、纤维化和炎症严重程度对于预后评估至关重要。本研究旨在评估一种新的肝脏脂肪变性定量系统——通用电气医疗保健公司的超声衰减参数(UGAP)的实用性,以受控衰减参数(CAP)作为参考方法。

材料和方法

179 例连续患者在同一次检查中使用 LOGIQ E10 系统(GE 医疗保健)上的 UGAP 和 CAP(FibroScan,EchoSens)评估肝脏脂肪变性。为了根据 CAP 区分脂肪变性阶段,我们使用了制造商推荐的截止值:S1(轻度)-230 dB/m,S2(中度)-275 dB/m,S3(重度)-300 dB/m。

结果

我们根据 CAP 将我们的队列分为以下组别:S0(无脂肪变性):48/176(27.2%),S1(轻度):56/176(31.6%),S2(中度):14/176(7.3%)和 S3(重度):59/176(33.9%)。随着脂肪变性程度的增加,UGAP 的平均值也增加,每个组的平均值分别为:S0:198.3±25.7 dB/m,S1:216.86±26.3 dB/m,S2:237.79±26.3 dB/m,S3:270.8±31.62 dB/m(p<0.001)。UGAP 值与 CAP 值之间存在非常好的正相关关系(r=0.73,p<0.0001)。使用 CAP 作为参考,预测不同等级肝脂肪变性的最佳截断值分别为:S1-192.5 dB/m(AUC 0.83);S2-231 dB/m(AUC 0.90)和 S3-248 dB/m(AUC 0.91)。

结论

UGAP 似乎是一种很好的肝脏脂肪变性定量方法,与 CAP 值密切相关。

相似文献

1
Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method.超声引导衰减参数(UGAP)用于定量肝脂肪变性,以受控衰减参数(CAP)作为参考方法。
Med Ultrason. 2021 Feb 18;23(1):7-14. doi: 10.11152/mu-2688. Epub 2020 Oct 8.
2
Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease.超声引导衰减参数作为非酒精性脂肪性肝病肝脂肪变的无创性检测的诊断准确性。
J Med Ultrason (2001). 2021 Oct;48(4):471-480. doi: 10.1007/s10396-021-01123-0. Epub 2021 Aug 20.
3
Correlation and Performance of three Ultrasound Techniques to Stage Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.三种超声技术对非酒精性脂肪性肝病肝脂肪变分期的相关性及效能比较。
Curr Med Imaging. 2024;20:1-12. doi: 10.2174/0115734056278434231213112035.
4
The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease.超声引导下的衰减参数在非酒精性脂肪性肝病肝脂肪变性的量化评估中很有用。
JGH Open. 2021 Jul 16;5(8):947-952. doi: 10.1002/jgh3.12615. eCollection 2021 Aug.
5
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.用于非酒精性脂肪性肝病中肝脂肪变性检测和定量的受控衰减参数
J Gastroenterol Hepatol. 2014;29(7):1470-6. doi: 10.1111/jgh.12557.
6
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.中国患者肝脏脂肪变性非侵入性评估的受控衰减参数
World J Gastroenterol. 2014 Apr 28;20(16):4702-11. doi: 10.3748/wjg.v20.i16.4702.
7
Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience.控制衰减参数评估肝脂肪变性与肝组织学的比较:单中心真实经验。
Swiss Med Wkly. 2019 Apr 26;149:w20077. doi: 10.4414/smw.2019.20077. eCollection 2019 Apr 22.
8
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.使用受控衰减参数(CAP)和瞬时弹性成像技术进行非侵入性诊断肝脂肪变性。
Liver Int. 2012 Jul;32(6):911-8. doi: 10.1111/j.1478-3231.2012.02820.x.
9
Ultrasound and FibroScan Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis.超声及 FibroScan 受控衰减参数在 MAFLD 患者中的应用:头对头比较评估肝脏脂肪变。
Endocrine. 2022 Nov;78(2):262-269. doi: 10.1007/s12020-022-03157-x. Epub 2022 Aug 18.
10
[Value of controlled attenuation parameter in diagnosis of fatty liver using FibroScan].[受控衰减参数在使用FibroScan诊断脂肪肝中的价值]
Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):108-13. doi: 10.3760/cma.j.issn.1007-3418.2016.02.007.

引用本文的文献

1
Comparison of Ultrasound-Based Techniques and Magnetic Resonance Imaging Proton Density Fat Fraction in Measuring the Amount of Hepatic Fat in Children with Hepatosteatosis.基于超声技术与磁共振成像质子密度脂肪分数在测量肝脂肪变性患儿肝脏脂肪含量中的比较
Medeni Med J. 2025 Jun 26;40(2):46-52. doi: 10.4274/MMJ.galenos.2025.34017.
2
Serum uric acid as a biomarker for metabolic dysfunction-associated steatotic liver disease: insights from ultrasound elastography in a Chinese cohort.血清尿酸作为代谢功能障碍相关脂肪性肝病的生物标志物:来自中国队列超声弹性成像的见解
BMC Gastroenterol. 2025 Feb 20;25(1):94. doi: 10.1186/s12876-025-03666-9.
3
Ultrasound-guided attenuation parameter for identifying metabolic dysfunction-associated steatotic liver disease: a prospective study.
超声引导下衰减参数用于识别代谢功能障碍相关脂肪性肝病:一项前瞻性研究。
Ultrasonography. 2025 Mar;44(2):134-144. doi: 10.14366/usg.24204. Epub 2024 Dec 19.
4
Non-Invasive Ultrasound Diagnostic Techniques for Steatotic Liver Disease and Focal Liver Lesions: 2D, Colour Doppler, 3D, Two-Dimensional Shear Wave Elastography (2D-SWE), and Ultrasound-Guided Attenuation Parameter (UGAP).用于脂肪性肝病和肝脏局灶性病变的非侵入性超声诊断技术:二维、彩色多普勒、三维、二维剪切波弹性成像(2D-SWE)以及超声引导下衰减参数(UGAP)。
Cureus. 2024 Oct 22;16(10):e72087. doi: 10.7759/cureus.72087. eCollection 2024 Oct.
5
Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease.超声引导下衰减参数和二维剪切波弹性成像在代谢功能障碍相关脂肪性肝病患者中的应用
Eur Radiol. 2025 Apr;35(4):2339-2350. doi: 10.1007/s00330-024-11076-w. Epub 2024 Oct 7.
6
Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications.影像学方法对肝脂肪变的无创评估:新技术及应用。
World J Gastroenterol. 2023 May 7;29(17):2534-2550. doi: 10.3748/wjg.v29.i17.2534.
7
Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial.适度碳水化合物限制饮食对非酒精性脂肪性肝病正常体重人群肝酶、脂肪变性和纤维化的影响:一项平行随机对照临床试验的研究方案。
BMJ Open. 2023 Apr 28;13(4):e063988. doi: 10.1136/bmjopen-2022-063988.
8
How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?为评估肝脂肪变性,我们应该重复测量超声引导下衰减参数多少次?
Ultrasonography. 2023 Apr;42(2):227-237. doi: 10.14366/usg.22122. Epub 2022 Oct 31.
9
The diagnostic value of novel ultrasound attenuation analysis in detecting liver steatosis identified by the controlled attenuation parameter: a diagnostic accuracy study.新型超声衰减分析在检测由受控衰减参数确定的肝脂肪变性中的诊断价值:一项诊断准确性研究。
Ann Transl Med. 2023 Jan 31;11(2):38. doi: 10.21037/atm-22-5821. Epub 2023 Jan 9.
10
Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal.评估肝脏脂肪变性的超声方法:批判性评价
Diagnostics (Basel). 2022 Sep 22;12(10):2287. doi: 10.3390/diagnostics12102287.